Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15990426 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation
Conditions: Alzheimer Disease;   Dementia
Intervention: Drug: galantamine hydrobromide

Indicates status has not been verified in more than two years